March 24, 2015—The Department of Health and Human Services has again urged a federal district judge to dismiss the drug industry’s lawsuit against the 340B orphan drug exclusion interpretive rule, saying the industry’s claim that the rule violates the Administrative Procedures Act has no merit.
You must be registered to read complete articles (it's quick, easy, and 100% free). Click here to register. Already registered? Click here to login. (340B Health members, Drug Discount Monitor subscribers, and 340B Coalition conference attendees: Use your existing username and password.)